Vanguard Personalized Indexing Management LLC boosted its position in shares of Inovio Pharmaceuticals, Inc. (NASDAQ:INO – Free Report) by 5.6% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 115,361 shares of the biopharmaceutical company’s stock after purchasing an additional 6,148 shares during the quarter. […]
Delcath Systems (NASDAQ:DCTH – Get Free Report) and Inovio Pharmaceuticals (NASDAQ:INO – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, dividends, analyst recommendations and valuation. Earnings & Valuation This table compares Delcath […]
Inovio Pharmaceuticals, Inc. (NASDAQ:INO – Free Report) – Equities research analysts at HC Wainwright lowered their Q2 2024 earnings estimates for shares of Inovio Pharmaceuticals in a report released on Tuesday, May 14th. HC Wainwright analyst R. Selvaraju now forecasts that the biopharmaceutical company will post earnings of ($1.28) per share for the quarter, down […]
Inovio Pharmaceuticals (NASDAQ:INO – Get Free Report) released its quarterly earnings data on Monday. The biopharmaceutical company reported ($1.31) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($1.08) by ($0.23), RTT News reports. Inovio Pharmaceuticals had a negative net margin of 16,238.91% and a negative return on equity of 80.79%. During […]